Two of the 59 inverse miRNA:mRNA target pairs we identified have been validated: miR-21:NFIB (an oncogenic interaction) in leukemia cells [42] and miR-195:CCND1 (a tumor-suppressive interaction) in hepatocellular carcinoma [43]. The gene discussed is CCND1; the disease is neoplasm.